Company Filing History:
Years Active: 2022-2025
Title: Innovations of Busen Wang in Viral Vector Systems
Introduction
Busen Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of viral vector systems for vaccine and drug preparation. With a total of two patents to his name, his work has the potential to impact public health significantly.
Latest Patents
One of his latest patents is titled "Single plasmid vector system for packaging recombinant human adenovirus type 4 and application thereof." This invention describes a vector system that includes an E3 region-deleted human adenovirus type 4 genome, a vector sequence for amplifying plasmids in bacteria, and a kanamycin resistance gene. The system allows for the rapid and efficient preparation of a human adenovirus type 4 vector recombinant virus, which can be used in the development of diagnostic kits, vaccines, and gene therapy.
Another notable patent is "Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein." This invention focuses on a nucleotide sequence for encoding the Marburg virus envelope glycoprotein and describes a human replication-deficient recombinant adenovirus capable of expressing this sequence. The application of this invention is particularly relevant in the preparation of vaccines against Marburg virus disease.
Career Highlights
Busen Wang is affiliated with the Academy of Military Medical Science, PLA. His work in this institution has allowed him to focus on innovative research in the field of viral vectors and their applications in medicine.
Collaborations
He has collaborated with notable coworkers such as Wei Chen and Shipo Wu, contributing to the advancement of research in viral vector systems.
Conclusion
Busen Wang's innovative work in the field of biotechnology, particularly in viral vector systems, showcases his commitment to advancing medical science. His patents have the potential to lead to significant breakthroughs in vaccine development and therapeutic applications.